AFT agrees three new deals for Maxigesic

2 October 2018 - Deborah Wilkes

Premium

New Zealand's AFT Pharmaceuticals has outlicensed its Maxigesic combination painkiller to three separate companies in Russia, Hong Kong and Taiwan.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: